Hidden Heroes of Health Care: Supporting a Shortage of Molecular Genetic Technologists

woman working in lab wearing a white coat

A Molecular Genetic Technologist is a qualified technologist (by an academic or applied education) that is able to perform testing on human samples for inherited diseases, acquired diseases and infectious diseases. According to the Mayo Clinic, these technologists analyze a patient's DNA to research, diagnose and treat many different diseases and disorders, such as cancers, congenital and nervous system disorders.

Ericka Hendrix, PhD, MB(ASCP), is a Professor and Program Director of Molecular Pathology M.S. at TTUHSC. We sat down with her to talk about the shortage of Molecular Genetic Technologists and how the TTUHSC Molecular Pathology Program is bringing awareness to the profession.

Shortage in Laboratory Sciences

    woman working in a lab in a white coat and gloves
TTUHSC’s Molecular Pathology Program is 1 of 8 in the U.S. that graduates students eligible to be certified in molecular biology
    
According to Hendrix, the shortage in these technologists is actually across all laboratory sciences, but it is greater in molecular science because it is a newer field.

The reason for this shortage? Current technologists are retiring, and COVID-19 pushed up that timeline for many after an increase in testing during that time. But because this field of health care is so “hidden,” there are not enough new technologists to fill the gaps. 

“As Molecular Genetic Technologists, we specifically test for things that we detect in DNA and RNA,”she says. “So, when we can detect viruses like COVID, our workload increases dramatically without any new people coming on board.”

Hendrix also explains that because of COVID, many labs bought molecular equipment to run tests to detect the virus. Now that the pandemic has subsided, a lot of those instruments aren’t being used because there is a shortage of professionals that have the skills to bring on new molecular diagnostic tests. 

Increasing Awareness

TTUHSC’s Molecular Pathology Program is one of eight in the nation that graduates students who are eligible to be certified in molecular biology, and to ultimately be able to perform this high complexity molecular diagnostic testing. 

TTUHSC’s one-year graduate program is the largest in the nation. To support this shortage in Molecular Genetic Technologists, Hendrix says the program has teamed up with professional organizations (i.e. Program Director Advisory Committee) to help support program directors in teaching molecular biology, to encourage including it in their courses, or to even start molecular programs. 

“We use Facebook for outreach,” Hendrix explains. “And I mentor new program directors to help keep these programs open and get new programs started.”

Hendrix says the TTUHSC Molecular Pathology Program is also trying to help this shortage by submitting an NIH grant to create workshops, so that people can learn the basics about molecular diagnostic testing in two weeks. 

“We're trying to raise awareness to get people interested in the field,” she says. “I think the major hurdle for our field is that people don't know about it.” 

Although there is currently a shortage of Molecular Genetic Technologists, Hendrix shares that the job growth rate in the field is expected to continue growing. She estimates that globally, it is currently a 17.3 billion dollar field, but by 2029 it is projected to be a 32.7 billion dollar field. 

“Our advanced techniques of being able to sequence whole genomes has really spurred the advancement of this field and the continued growth,” Hendrix says. “But we need technologists that can run and analyze that really complex data.” 

Related Stories

Education

Texas Tech University Health Sciences Center’s Klein Selected to Leadership Role by the Texas Pharmacy Association

The Texas Pharmacy Association announced (May 19) the appointment of Mary Klein, Pharm.D., as assistant vice president of Strategic Initiatives and Practice Innovation.

Education

TTUHSC Celebrates Class of 2026 with Commencement Ceremonies

Texas Tech University Health Sciences Center hosted commencement ceremonies for all six schools to honor graduates of the Class of 2026.

Education

Schroeder Named Texas Tech University Health Sciences Center Permian Basin School of Medicine Regional Dean

Brian D. Schroeder, M.D., has been named the TTUHSC School of Medicine regional dean in the Permian Basin, effective May 1. Schroeder has served as the interim Jan & Ted Roden Endowed Chair and regional dean since May 2025.

Recent Stories

Research

TTUHSC Experts Receive Junior Investigator Research Grants through Texas Alzheimer’s Research and Care Consortium

Texas Tech University Health Sciences Center (TTUHSC) researchers Aric Logsdon, Ph.D., and Jonathan Singer, Ph.D., received Junior Investigator Research Grants from the Texas Alzheimer’s Research and Care Consortium (TARCC).

Research

CPRIT Awards TTUHSC Researcher $1.4 Million Cancer Grant in Efforts to Expand Rural Clinical Trials

The Cancer Prevention and Research Institute of Texas (CPRIT) awarded a $1.4 million grant to Erin Barr, M.D., a clinician of pediatric hematology/oncology and researcher in the School of Medicine at Texas TTUHSC. Barr’s research, “Enhancing access to pediatric oncology clinical trials in West Texas,” received funding under the Recruitment or Retention of Clinical Trialists Award.

Education

Texas Tech University Health Sciences Center’s Klein Selected to Leadership Role by the Texas Pharmacy Association

The Texas Pharmacy Association announced (May 19) the appointment of Mary Klein, Pharm.D., as assistant vice president of Strategic Initiatives and Practice Innovation.